Trademarkia Logo

Canada

C$
Trademark Search in Canada
KIROVYZE

View On IC.GC.CA

KIROVYZE
APPROVED

on 30 Jan 2025

Last Applicant/ Owned by

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250 Palo Alto CA 94304

US

Serial Number

2234489 filed on 21st Dec 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

KIROVYZE

Trademark usage description

pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and diso Read More

Classification Information

Class [005]
Pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases, neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, and cerebral palsy, genetic diseases and disorders, orthopedic diseases and disorders, namely, arthritis, osteoporosis, fibromyalgia, and metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity, hyperlipidemia, insulin resistance, metabolic syndrome.

Classification kind code

11

Mark Details

Serial Number

2234489

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 135
on 14th Mar 2024		Amendment to Application
Submitted for opposition 22
on 8th Jan 2024		Search Recorded
Submitted for opposition 20
on 8th Jan 2024		Examiner's First Report
Submitted for opposition 223
on 8th Jan 2024		Total Provisional Refusal
Submitted for opposition 256
on 20th Nov 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 19th Jan 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 18th Jan 2023		Created
Submitted for opposition 31
on 18th Jan 2023		Formalized
Submitted for opposition 30
on 21st Dec 2022		Filed
Submitted for opposition 228
on 21st Dec 2022		International Registration